Phase III sole-source authority backs every contract under the revenue curve. The recurring revenue is the operational expression of that anchor. Most investors see one number. We’d show three.
The shift from hours to outcomes, from labor rates to unit pricing, is what transforms your economics.
Most investors look for recurring revenue and stop there. Recurring revenue is the right number to track. But the underlying anchor is what backs it. For NorthAI, that anchor is Phase III sole-source authority, which is already unlocked on the basis of FA8649-21-P-0756.
15 U.S.C. 638(r)(4)(B) authorizes federal agencies to issue Phase III awards to Phase I awardees, without further justification, without a J&A, and without a FAR Part 5 synopsis. The SBA Policy Directive Section 9 is explicit: a federal agency may enter Phase III at any time with a Phase I awardee. Phase II is an option. It is not a gate. CHN holds the predicate. The CO action memo is the first deliverable, not a milestone twelve months away.
What that means for the raise: every productized-service contract that runs under Phase III authority is not a services contract in the conventional sense. It is a federal sole-source award backed by statute. Investors who have seen FedGov deals know the difference. The valuation conversation shifts when the diligence room contains a Phase III contract, not just recurring revenue numbers that look like any other SaaS line. Phase III is the anchor. Recurring revenue is the operational expression of that anchor, built on top of it.
Today, our best estimate of the revenue mix is roughly 70-80% T&M and labor-hour billing on the CHN side, with near-zero recurring or subscription revenue from the NorthAI brand. The target by end of FY26 is to bring the labor-cost-to-revenue ratio from roughly 70% toward 60%, with recurring revenue moving from near-zero to roughly 30-40% of trailing-twelve-months revenue. That ratio is the single number that anchors the raise-multiples conversation. Pure services firms exit at 0.8-1.2x EV/Rev. Tech-enabled services exit at 1.5-3x. SaaS with growth and retention exits at 4-12x.
The addressable market for NorthAI’s specific niche (RDT&E budget-foresight tooling, technology-intelligence platforms, BD-side decision support for senior federal buyers) runs roughly $800 million to $1.2 billion. At $165,000-$235,000 ACV per account on a productized-service basis, thirty accounts is a $5-7M ARR business. That is within reach in 24 months given the warm-relationship base you already carry from the OSI&A period. The TAM is not the constraint. The vehicle posture and the SKU definition are.
Most investors reviewing a federal tech company see one number: recurring revenue as a percentage of TTM revenue. That number is load-bearing for the multiple. But the number by itself does not tell the investor whether the revenue is defensible or accidental. Federal recurring revenue that runs on productized-service contracts under Phase III sole-source authority is structurally different from recurring revenue that runs on T&M agreements under a prime’s vehicle. The former is harder to displace. A competitor cannot simply underbid. The Phase III authority follows the awardee.
The diligence-room artifact we’d build around this shows three numbers, not one: Phase III contracts in the pipeline (qualified, with CO memo in progress), Phase III contracts signed (executed, with associated CLIN and ACV), and recurring revenue from those contracts (trailing twelve months, growth rate). Those three numbers compound. A pipeline entry becomes a signed contract. A signed contract becomes recurring revenue. The recurring revenue percentage rises. The multiple moves. Investors who have seen federal tech deals at scale recognize that sequence immediately.
The framing from the call, “sometimes you have to kind of commit to six, 12, 18 months of pain,” describes exactly what those three numbers look like at the start. The compounding starts to show by month 9. By the time the raise closes, the diligence-room math we’d want is: ARR over $1M with verifiable growth trajectory, recurring revenue percentage above 25%, gross margin on the productized SKUs north of 60%, two named customers with second-contract renewal signal in hand, and at least one Phase III contract signed.
The AFWERX STTR Phase I under topic AF20C-TCSO1 opens multiple forward paths, not one. Direct Phase III is the path most firms in this position do not know is available. As covered on the watch page, the statute authorizes it without Phase II as a prerequisite. The CO action memo is the unlock. For Tech Vector specifically, the derives-from argument is textually direct: the Phase I scope was building an AI method to identify commercialization partners for government-funded research via patents, grants, and financial data. That is what Tech Vector does. One CO memo and a program office contact is the mechanism.
Direct-to-Phase II is a parallel path, not a prior gate. Prior Phase I winners apply for Phase II without re-qualifying, provided they secure a signed customer memo from an Air Force end-user. The Phase II award is approximately $1.25M over 21 months and unlocks additional Phase III authority on that scope. Running Phase III pursuit and Phase II application simultaneously is the right posture. The engagement does not wait on Phase II before approaching program office contacts about Phase III. The Phase II provides bridge funding and strengthens the pipeline while Phase III awards are executing.
The existing STTR Phase I vehicle is sufficient. Phase III sole-source authority routes directly from it under 638(r)(4)(B). The Phase I vehicle is not the ceiling. It is the floor that lets CHN sign paper while the Phase III CO memo is in progress. GSA MAS and OTA/CSO motion are the fallback paths if the prime relationship turns out to be cold. They are longer arcs (six to twelve months to vehicle access), which is why the Phase III track is the primary near-term path and the one the engagement builds first.